Tops & Flops Stocks
| Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Onxeo S.A. | -2.780% | -9.091% | 3.321% | 98.864% | 68.878% | -13.259% | -80.226% |
| Oncotherapy Science Inc. | - | 4.372% | -12.385% | -44.152% | -6.373% | -75.638% | -89.505% |
| Oncopeptides AB | 4.050% | 1.140% | 15.094% | 263.636% | 271.385% | -58.609% | -96.841% |
| Oncolytics Biotech | -4.730% | - | - | - | - | - | - |
| Oncolys Biopharma Inc. | 2.790% | - | - | - | - | - | - |
| OncoCyte Corp | -3.610% | - | - | - | - | - | - |
| Oncimmune Holdings PLC | - | - | - | - | - | - | - |
| Omnicell Inc. | -3.700% | 5.202% | 14.465% | -16.514% | -12.500% | -19.469% | -61.684% |
| Omeros Corp. | -7.140% | -3.360% | 51.874% | 10.952% | -20.045% | 335.941% | -22.814% |
| Olympus Corp. | -2.990% | -2.616% | -6.791% | -26.970% | -23.724% | -40.568% | -37.131% |
| Olainfarm AS | -1.130% | - | - | - | - | - | - |
| Ocuphire Pharma Inc. | 0.960% | 2.145% | 17.647% | 85.874% | 80.180% | -31.973% | - |
| Ocular Therapeutix Inc. | -0.200% | 16.307% | 28.176% | 46.034% | 54.931% | 369.365% | -27.427% |
| Nymox Pharmaceutical Corp. | 5.410% | - | - | - | - | - | - |
| Nxstage Medical | - | - | - | - | - | - | - |
| Nuwellis Inc. | - | - | - | - | - | - | - |
| Nuvo Pharmaceuticals Inc. | -1.640% | - | - | - | - | - | - |
| Nuvectra Corp | -23.080% | - | - | - | - | - | - |
| Nuvasive Inc. | 0.510% | - | - | - | - | - | - |
| Novo Nordisk A/S ADR | -0.230% | 4.015% | -1.384% | -58.894% | -48.864% | -65.385% | -25.652% |
| Novo Nordisk A/S | -0.080% | - | - | - | - | - | - |
| Novocure Ltd | -1.160% | 9.135% | 15.722% | -60.508% | -61.023% | -84.133% | -91.990% |
| Novavax Inc. | -1.750% | -5.548% | -9.778% | -35.046% | -28.858% | -63.920% | -94.563% |
| Novartis AG ADR | 0.000% | -0.877% | -1.310% | 19.958% | 19.703% | 31.090% | 47.712% |
| Novan Inc | -97.780% | - | - | - | - | - | - |